Trends in net survival from corpus uteri cancer in six European Latin countries: Results from the SUDCAN population-based study

L. Antunes, L. Roche, M.J. Bento, Diego Serraino, Antonella Zucchetto

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Corpus uteri cancer is the most common gynaecological cancer in women in Europe, but presents a relatively good prognosis. There were two main objectives in this study: estimate differences between countries in agestandardized net survival (NS) at 1 and 5 years in 2000-2004 and evaluate time trends in NS and excess mortality rates in 1992-2004. Data on corpus uteri malignant tumours (International Classification of Diseases for Oncology, third ed.: C54) were extracted from the EUROCARE database for six European Latin countries: Belgium, France, Italy, Portugal, Spain and Switzerland. NS was estimated for each country using the nonparametric estimator proposed by Pohar-Perme. Trends in NS and excess mortality rates up to 5 years after diagnosis were assessed using a multivariable parametric flexible modelling. The study analysed 25 508 cases for the first objective and 43 550 for the second. Age-standardized 1-year NS ranged from 88% (Portugal and Spain) to 93% (Switzerland), whereas 5-year survival ranged between 72% (Portugal) and 79% (Belgium and Switzerland). From 1992 to 2004, the NS increased in all countries with available information on this period (France, Italy, Spain and Switzerland). Also, in Belgium and Portugal, there was an increase in NS between 2000 and 2004. Improvements in survival were more evident for older ages (75 years). There were some differences in NS between the countries studied (maximum of 5% at 1 year and 7% at 5 years). The NS improved in all countries during the period studied and the differences between countries narrowed. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.
Original languageEnglish
Pages (from-to)S100-S106
Number of pages7
JournalEuropean Journal of Cancer Prevention
Volume26
Issue numbersupp 1
DOIs
Publication statusPublished - 2017

Fingerprint

Uterine Neoplasms
Survival
Portugal
Population
Switzerland
Belgium
Spain
Mortality
Italy
France
International Classification of Diseases
Uterus
Neoplasms
Databases

Keywords

  • Cancer registries
  • Corpus uteri cancer
  • Europe
  • Excess mortality rate
  • Latin countries
  • Net survival
  • Trend analysis
  • adult
  • Article
  • Belgium
  • cancer diagnosis
  • cancer mortality
  • cancer survival
  • female
  • France
  • human
  • ICD-O-3
  • Italy
  • major clinical study
  • malignant neoplasm
  • middle aged
  • mortality rate
  • net survival
  • oncological parameters
  • Portugal
  • priority journal
  • Spain
  • survival
  • Switzerland
  • trend study
  • uterus cancer

Cite this

Trends in net survival from corpus uteri cancer in six European Latin countries: Results from the SUDCAN population-based study. / Antunes, L.; Roche, L.; Bento, M.J.; Serraino, Diego; Zucchetto, Antonella.

In: European Journal of Cancer Prevention, Vol. 26, No. supp 1, 2017, p. S100-S106.

Research output: Contribution to journalArticle

@article{30c2d297478c4fd686f1a7e05011c57e,
title = "Trends in net survival from corpus uteri cancer in six European Latin countries: Results from the SUDCAN population-based study",
abstract = "Corpus uteri cancer is the most common gynaecological cancer in women in Europe, but presents a relatively good prognosis. There were two main objectives in this study: estimate differences between countries in agestandardized net survival (NS) at 1 and 5 years in 2000-2004 and evaluate time trends in NS and excess mortality rates in 1992-2004. Data on corpus uteri malignant tumours (International Classification of Diseases for Oncology, third ed.: C54) were extracted from the EUROCARE database for six European Latin countries: Belgium, France, Italy, Portugal, Spain and Switzerland. NS was estimated for each country using the nonparametric estimator proposed by Pohar-Perme. Trends in NS and excess mortality rates up to 5 years after diagnosis were assessed using a multivariable parametric flexible modelling. The study analysed 25 508 cases for the first objective and 43 550 for the second. Age-standardized 1-year NS ranged from 88{\%} (Portugal and Spain) to 93{\%} (Switzerland), whereas 5-year survival ranged between 72{\%} (Portugal) and 79{\%} (Belgium and Switzerland). From 1992 to 2004, the NS increased in all countries with available information on this period (France, Italy, Spain and Switzerland). Also, in Belgium and Portugal, there was an increase in NS between 2000 and 2004. Improvements in survival were more evident for older ages (75 years). There were some differences in NS between the countries studied (maximum of 5{\%} at 1 year and 7{\%} at 5 years). The NS improved in all countries during the period studied and the differences between countries narrowed. Copyright {\circledC} 2017 Wolters Kluwer Health, Inc. All rights reserved.",
keywords = "Cancer registries, Corpus uteri cancer, Europe, Excess mortality rate, Latin countries, Net survival, Trend analysis, adult, Article, Belgium, cancer diagnosis, cancer mortality, cancer survival, female, France, human, ICD-O-3, Italy, major clinical study, malignant neoplasm, middle aged, mortality rate, net survival, oncological parameters, Portugal, priority journal, Spain, survival, Switzerland, trend study, uterus cancer",
author = "L. Antunes and L. Roche and M.J. Bento and Diego Serraino and Antonella Zucchetto",
note = "Export Date: 20 February 2018 CODEN: EJUPE Correspondence Address: Bento, M.J.; Instituto Portugu{\^e}s de Oncologia Francisco Gentil do Porto, Rua Dr Ant{\'o}nio Bernardino de Almeida, Portugal; email: mjbento@ipoporto.min-saude.pt",
year = "2017",
doi = "10.1097/CEJ.0000000000000294",
language = "English",
volume = "26",
pages = "S100--S106",
journal = "European Journal of Cancer Prevention",
issn = "0959-8278",
publisher = "Lippincott Williams and Wilkins",
number = "supp 1",

}

TY - JOUR

T1 - Trends in net survival from corpus uteri cancer in six European Latin countries: Results from the SUDCAN population-based study

AU - Antunes, L.

AU - Roche, L.

AU - Bento, M.J.

AU - Serraino, Diego

AU - Zucchetto, Antonella

N1 - Export Date: 20 February 2018 CODEN: EJUPE Correspondence Address: Bento, M.J.; Instituto Português de Oncologia Francisco Gentil do Porto, Rua Dr António Bernardino de Almeida, Portugal; email: mjbento@ipoporto.min-saude.pt

PY - 2017

Y1 - 2017

N2 - Corpus uteri cancer is the most common gynaecological cancer in women in Europe, but presents a relatively good prognosis. There were two main objectives in this study: estimate differences between countries in agestandardized net survival (NS) at 1 and 5 years in 2000-2004 and evaluate time trends in NS and excess mortality rates in 1992-2004. Data on corpus uteri malignant tumours (International Classification of Diseases for Oncology, third ed.: C54) were extracted from the EUROCARE database for six European Latin countries: Belgium, France, Italy, Portugal, Spain and Switzerland. NS was estimated for each country using the nonparametric estimator proposed by Pohar-Perme. Trends in NS and excess mortality rates up to 5 years after diagnosis were assessed using a multivariable parametric flexible modelling. The study analysed 25 508 cases for the first objective and 43 550 for the second. Age-standardized 1-year NS ranged from 88% (Portugal and Spain) to 93% (Switzerland), whereas 5-year survival ranged between 72% (Portugal) and 79% (Belgium and Switzerland). From 1992 to 2004, the NS increased in all countries with available information on this period (France, Italy, Spain and Switzerland). Also, in Belgium and Portugal, there was an increase in NS between 2000 and 2004. Improvements in survival were more evident for older ages (75 years). There were some differences in NS between the countries studied (maximum of 5% at 1 year and 7% at 5 years). The NS improved in all countries during the period studied and the differences between countries narrowed. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.

AB - Corpus uteri cancer is the most common gynaecological cancer in women in Europe, but presents a relatively good prognosis. There were two main objectives in this study: estimate differences between countries in agestandardized net survival (NS) at 1 and 5 years in 2000-2004 and evaluate time trends in NS and excess mortality rates in 1992-2004. Data on corpus uteri malignant tumours (International Classification of Diseases for Oncology, third ed.: C54) were extracted from the EUROCARE database for six European Latin countries: Belgium, France, Italy, Portugal, Spain and Switzerland. NS was estimated for each country using the nonparametric estimator proposed by Pohar-Perme. Trends in NS and excess mortality rates up to 5 years after diagnosis were assessed using a multivariable parametric flexible modelling. The study analysed 25 508 cases for the first objective and 43 550 for the second. Age-standardized 1-year NS ranged from 88% (Portugal and Spain) to 93% (Switzerland), whereas 5-year survival ranged between 72% (Portugal) and 79% (Belgium and Switzerland). From 1992 to 2004, the NS increased in all countries with available information on this period (France, Italy, Spain and Switzerland). Also, in Belgium and Portugal, there was an increase in NS between 2000 and 2004. Improvements in survival were more evident for older ages (75 years). There were some differences in NS between the countries studied (maximum of 5% at 1 year and 7% at 5 years). The NS improved in all countries during the period studied and the differences between countries narrowed. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.

KW - Cancer registries

KW - Corpus uteri cancer

KW - Europe

KW - Excess mortality rate

KW - Latin countries

KW - Net survival

KW - Trend analysis

KW - adult

KW - Article

KW - Belgium

KW - cancer diagnosis

KW - cancer mortality

KW - cancer survival

KW - female

KW - France

KW - human

KW - ICD-O-3

KW - Italy

KW - major clinical study

KW - malignant neoplasm

KW - middle aged

KW - mortality rate

KW - net survival

KW - oncological parameters

KW - Portugal

KW - priority journal

KW - Spain

KW - survival

KW - Switzerland

KW - trend study

KW - uterus cancer

U2 - 10.1097/CEJ.0000000000000294

DO - 10.1097/CEJ.0000000000000294

M3 - Article

VL - 26

SP - S100-S106

JO - European Journal of Cancer Prevention

JF - European Journal of Cancer Prevention

SN - 0959-8278

IS - supp 1

ER -